MEDINET MEDINET is a contract development and manufacturing organization (CDMO) focused on the cancer immuno-cell therapy. | ![]() OncoTherapy Science OncoTherapy Science is a company engaged in research and development of cancer therapeutics. | ![]() Iksuda Therapeutics Iksuda is a biotechnology company that focuses on developing antibody-based therapies for the treatment of cancer. | |
Founding Date | Founding Date 1995 | Founding Date 2001 | Founding Date 2007 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Ota City, JP HQ Shinagawa City, JP | Locations Kawasaki, JP HQ | Locations Newcastle upon Tyne, GB HQ Newton, US |
Employees | Employees 92 | Employees 54 | Employees 43 |
Valuation ($) | Valuation ($) 70.2 m | Valuation ($) 56.9 m | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) ¥810.3m (FY, 2025) | Revenue (est.) ¥808.5m (FY, 2026) | Revenue (est.) N/A |
Cost of goods | Cost of goods ¥625.3m (FY, 2025) | Cost of goods ¥794.6m (FY, 2026) | Cost of goods N/A |
Gross profit | Gross profit ¥185m (FY, 2025) | Gross profit ¥14m (FY, 2026) | Gross profit N/A |
Net income | Net income (¥1.4b) (FY, 2025) | Net income (¥910.6m) (FY, 2026) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 4.3m | Total funding raised N/A | Total funding raised $ 47m |

OncoTherapy Science is a company engaged in research and development of cancer therapeutics.
View company
Iksuda is a biotechnology company that focuses on developing antibody-based therapies for the treatment of cancer.
View company